Delivery Order SPE2DB22D1202-SPE2DB24FVMP6

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,473,890 units of Citalopram HBR 40 mg tablets. The fixed-price delivery order has a ceiling value of $28,331.92 and an ultimate completion date of October 16, 2023. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This federal contract award, valued at $1,166.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,873,359 tablets of the medication Citalopram HBR 40 mg, with a completion date of April 11, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $13,586.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,077 units of the prescription medication Citalopram Hydrobromide 40 mg tablets. The contract has an ultimate completion date of October 11, 2024 and is structured as a firm-fixed-price delivery order. This contract is not designated as a set-aside. AmerisourceBergen holds several large...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,680,284 units of Citalopram HBR 40 mg tablets. The $3,805.46 firm fixed-price Delivery Order has a completion date of February 16, 2024 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that provides a comprehensive range of pharmaceutical products and medical supplies to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $20,622.55, is a delivery order awarded by the Defense Logistics Agency (DLA) for the supply of 4,566,066,792 tablets of Citalopram HBR 40 mg. The contract has an ultimate completion date of October 10, 2024 and is a firm fixed-price contract. Amerisourcebergen, through its Corporate Office division, is the prime contractor for this award, which is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,873,036 units of the medication Citalopram HBR 40 mg tablets. The award, valued at $2,021.86, is a Firm Fixed Price Delivery Order with a completion date of November 22, 2023. The contract was not set aside for any specific program or business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $11,962.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,600 units of Citalopram Hydrobromide 40mg tablets, a pharmaceutical product used to treat mental health conditions. This is a firm-fixed-price delivery order contract with a completion date of December 4, 2024. The contract was not set aside for any...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of citalopram hydrochloride 40 mg tablets. The contract has a ceiling value of $5,110.08 and an ultimate completion date of August 14, 2024. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,474,076 units of the drug Citalopram HBR 40 mg tablets, with a ceiling value of $4,172.32. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is October 16, 2023. This award is a part of a larger Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a $5,292.46 firm-fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, to supply 4,565,406,862 tablets of Citalopram HBR 40 mg. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVMP6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,667,893 tablets of citalopram hydrochloride 40 milligram medication. The contract is a firm fixed-price delivery order with a ceiling value of $24,106.88 and a completion date of September 4, 2024. The contract has no set-aside designation. As a large pharmaceutical supplier, Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, such as the Department of Justice Federal Bureau of Investigation, to provide a wide range of essential medical commodities, including specialty medications, generic drugs, and medical supplies, in support of military treatment facilities, veterans' healthcare programs, and other government healthcare initiatives.

Generated 12/3/24, 9:50 AM